Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCK | P27707 | 11/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 2/20 | 0.31 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL599496 | 0.90 | DCK (0.37) | DCKALBCDK2SMN1; SMN2 | |
| SCHEMBL598541 | 0.89 | DCK (0.37) | DCKALBTSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL598439 | 0.85 | ALB (0.36) | DCKALB | |
| SCHEMBL598272 | 0.83 | DCK (0.35) | DCKALB | |
| SCHEMBL597635 | 0.83 | ALB (0.35) | ALB | |
| SCHEMBL599086 | 0.82 | EP300 (0.37) | ALB | |
| SCHEMBL598689 | 0.82 | DCK (0.39) | DCKALBNPC1CDK2SMN1; SMN2 | |
| SCHEMBL599309 | 0.81 | ALB (0.33) | ALB | |
| SCHEMBL597780 | 0.80 | ALB (0.39) | ALB | |
| SCHEMBL597288 | 0.78 | DCK (0.45) | DCKALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8114997-B2 | N4-acylcytosine nucleosides for treatment of viral infections | PHARMASSET, INC. (US) | 2012-02-14 | — | — | US | disclosed |